Pharmaceutical Drug Delivery Market Market Opportunities in Drug Delivery, Capsule Endoscopy, Patient Monitoring Drives the Global Industry Share at Highly Promising CAGR till the End – 2027
Pharmaceutical drug delivery is referred as transfer of drug into the patient’s body for the therapeutic effect (treatment). Drug delivery system is classified into two types such as conventional drug delivery system and novel drug delivery system. Conventional drug delivery system includes the most common methods of drug delivery through various routes such as oral (through mouth), topical (skin), and Transmucosal (nasal, buccal, sublingual, vaginal, rectal, and ocular). This system will help to modify absorption, distribution, metabolism, and elimination of drugs for the patient’s convenience.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/2633
Novel drug delivery system includes the sustained release (SR) drug and controlled release drug. Sustained release indicate slow release of drug and controlled release means where speed of drug release is controlled. These are helpful for maintaining drug level into the blood and improve targeted drug release.
Global Pharmaceutical drug Delivery Market Drivers
Increasing approval of new drugs from U.S. FDA is expected to drive growth of the global pharmaceutical drug delivery market. For instance, in April 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Duobrii (contains-halobetasol propionate and tazarotene), which is used for the treatment of plaque psoriasis. It is manufactured by Ortho Dermatogics Company.
Furthermore, new product launches is expected to boost the global pharmaceutical drug delivery market. For instance, in August 2018, Sanofi Genzyme launched new drug (Aubagio) for the treatment of multiple sclerosis. Aubagio offers once-a-day treatment and ease of convenience for the patient.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2633
Moreover, in April 2019, Pfizer launched trastuzumab (trazimera) for the treatment of metastatic HER2 (Human Epidermal Growth Factor2)-positive breast cancer and HER2–positive metastatic gastric cancer. Hence, these products are expected to boost the global pharmaceutical drug delivery market.
Global Pharmaceutical Drug Delivery Market Restraints
Drug shortage is projected to hamper growth of the global pharmaceutical drug delivery market. For instance, according New York Times report in February 2019, Buspirone HCL Tablets -7.5mg manufactured by Accord Healthcare Inc. was on shortage, due to high demand for the drug for the anxiety treatment.
Furthermore, in September 2018, Union Health Ministry of India banned 328 FDC (Fixed Dose Composition) drugs due to irrational use of FDC drugs. Some other examples of banned drugs-Aceclofenac (SR) + Paracetamol 750, Aceclofenac + Paracetamol + Famotidine, naproxen plus paracetamol. Such ban of drugs will affect growth of global pharmaceutical drug delivery market.
Global Pharmaceutical Drug Delivery Market- Regional Analysis
On the basis of region, global pharmaceutical drug delivery market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global pharmaceutical drug delivery market, owing to increasing research and development activities in the region. For instance, in April 2019, Abbvie Pharmaceutical received an approval from U.S. Food and Drug Administration (FDA) for a new drug known as SKYRIZI (risankizumab), which is used for the treatment of Plaque Psorisis.
Browse Full Report Details @ https://www.coherentmarketinsights.com/ongoing-insight/pharmaceutical-drug-delivery-market-2633
Furthermore, Asia Pacific is also projected to witness significant growth in the global pharmaceutical drug delivery market during the forecast period, owing to increasing new launches of products. For instance, in April 2019, Glenmark launched its anti-diabetic medicine (SGLT2 inhibitor Remogliflozin) in India. This drug is used for the treatment of type-2 diabetes mellitus in adults. It is administered via oral route.
Key players operating in the global pharmaceutical drug delivery market include Johnson and Johnson, Merck & Co, Inc., Bayer AG, Pfizer, Inc., Novartis AG, Sanofi, Antares Pharma, Inc., Accord Healthcare, Inc., Abbott, and GSK.
Global Pharmaceutical drug Delivery Market-Taxonomy
By Route of Administration
- Oral Drug Delivery
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-Solid Oral Drugs
- Topical Drug Delivery
- Liquid Formulation
- Semi-Solid Formulation
- Solid Formulation
- Transdermal Products
- Pulmonary Drug Delivery
- Metered-Dose Inhalers
- Dry Powder Inhalers
- Nasal Drug Delivery
- Nasal Drops
- Nasal Sprays
- Nasal Powders
- Nasal Gels
- Transmucosal Drug Delivery
- Oral Formulations
- Injectable Drug Delivery
- Conventional Injection Devices
- Self-Injection Devices
- Ocular Drug Delivery
- Liquid Formulations
- Semi-Solid Formulations
- Ocular Devices
- Implantable Drug Delivery
- Active Implantable Drug Delivery
- Passive Implantable Drug Delivery
- Infectious Diseases
- Cardiovascular Diseases
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Ambulatory Surgical Centers/ Clinics
- Diagnostic Centers
- North America
- Asia Pacific
- Latin America
- Middle East
Other Related Reports:
Saudi Arabia Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over-the-counter (OTC) Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Nervous System, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others (Nutraceutical, dentals and veterian)), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy , and Online Pharmacy ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Europe Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over the Counter Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Nervous System, Genito-urinary, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and by Country/Region (Germany, France, U.K., Italy, Spain, Russia, The Netherlands, Poland, Switzerland, Sweden, and Rest of Europe) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire